BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19037997)

  • 1. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats.
    Hanada M; Baba A; Tsutsumishita Y; Noguchi T; Yamaoka T
    Cancer Sci; 2009 Jan; 100(1):189-94. PubMed ID: 19037997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.
    Hanada M; Baba A; Tsutsumishita Y; Noguchi T; Yamaoka T; Chiba N; Nishikaku F
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):473-83. PubMed ID: 19104812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
    Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced hepatocellular carcinoma effectively treated with 5-fluorouracil and high-concentration cisplatin suspended in lipiodol by short-term hepatic arterial infusion chemotherapy].
    Yata Y; Kanda D; Takeuchi S; Hatanaka T; Iesaki K; Yoshinaga T; Kubota J; Higuchi T
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1179-81. PubMed ID: 19620813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).
    Watanabe S; Nitta N; Ohta S; Sonoda A; Otani H; Tomozawa Y; Nitta-Seko A; Tsuchiya K; Tanka T; Takahashi M; Murata K
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):399-405. PubMed ID: 21584842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor.
    Hayashi Y; Fukushima S; Kishimoto S; Kawaguchi T; Numata M; Isoda Y; Hirano J; Nakano M
    Cancer Res; 1992 Jan; 52(2):400-5. PubMed ID: 1309442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcatheter arterial chemotherapy using a novel lipophilic platinum derivative (miriplatin) for patients with small and multiple hepatocellular carcinomas.
    Yukisawa S; Ishii H; Kasuga A; Matsuyama M; Kuraoka K; Takano K; Ozaka M
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):583-8. PubMed ID: 22330234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is associated with increased Bcl-2 expression, leading to defects in inducing apoptosis.
    Hanada M; Takasu H; Kitaura M
    Oncol Rep; 2010 Oct; 24(4):1011-8. PubMed ID: 20811683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (I)--Preparation of LPS and its anticancer effect on a rabbit liver cancer model after injection into the hepatic artery].
    Fukushima S; Kishimoto S; Hayashi Y; Kaneko M; Nakano M; Shibata J; Fujiyama S; Sato T
    Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2743-9. PubMed ID: 2854837
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective accumulation and tumoricidal effect of cisplatin suspended in viscous ethyl oleate on hepatic cancers in animals after intraarterial infusion.
    Natsume H; Imamizu M; Sugibayashi K; Shibata T; Miyagawa A; Morimoto Y
    J Drug Target; 1993; 1(3):207-15. PubMed ID: 8069562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new lipophilic prodrug 3', 5'-dioctanoyl-5-bromodeoxyuridine (BrdU-C8) suspended in Lipiodol as a radiosensitizer for the treatment of AH136B tumor.
    Ohara C; Beppu T; Yamaguchi Y; Masuda Y; Fukushima S; Kawaguchi T; Ogawa M
    Anticancer Res; 1993; 13(3):655-60. PubMed ID: 8391245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-growing rat hepatic tumor after intra-hepatic arterial administration.
    Kishimoto S; Noguchi T; Yamaoka T; Fukushima S; Takeuchi Y
    Biol Pharm Bull; 2000 Mar; 23(3):344-8. PubMed ID: 10726891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol].
    Hoshino M; Koyama Y; Sugano K; Kanno M; Satou N; Abe R
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2810-3. PubMed ID: 2551224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
    Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.